J. Goldman & Co’s Ventyx Biosciences VTYX Stock Holding History

J. Goldman & Co’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,406	Closed	-$157K	–	906
2025 Q4	$157K	Buy	+17,406	New	+$130K	﹤0.01%	521
2024 Q2	–	Sell	-62,262	Closed	-$342K	–	606
2024 Q1	$342K	Buy	+62,262	New	+$285K	0.01%	347

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

J. Goldman & Co's VTYX Position: Q1 2026 in Review

J. Goldman & Co sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 17,406 shares — an estimated $157K sold.

J. Goldman & Co first reported a position in VTYX in Q1 2024 and held it in 2 quarters. The position peaked at $342K in Q1 2024. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

J. Goldman & Co reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
J. Goldman & Co sold 17,406 Ventyx Biosciences shares in Q1 2026, an estimated $157K.
J. Goldman & Co first reported a position in Ventyx Biosciences in Q1 2024 and held it in 2 quarters.
J. Goldman & Co's Ventyx Biosciences position peaked at $342K in Q1 2024.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.